First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer GroupMarinde J. G. Bond, Johanneke H.M.J.V. Vestjens, Karen Bolhuis et al.|The Lancet Oncology|2023Cited by 168
Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6)Koen P. Rovers, Aeilko H. Zwinderman, Checca Bakkers et al.|BMC Cancer|2019Cited by 111
MRI in addition to CT in patients scheduled for local therapy of colorectal liver metastases (CAMINO): an international, multicentre, prospective, diagnostic accuracy trialBurak Görgeç, Werner A. Draaisma, Daan J. Lips et al.|The Lancet Oncology|2023Cited by 65
First-Line Systemic Treatment for Initially Unresectable Colorectal Liver MetastasesMarinde J. G. Bond, Leonie J. Mekenkamp, Karen Bolhuis et al.|JAMA Oncology|2024Cited by 26
Prognostic value of total tumor volume in patients with colorectal liver metastases: A secondary analysis of the randomized CAIRO5 trial with external cohort validationJ Michiel Zeeuw, Geert Kazemier, Nina J. Wesdorp et al.|European Journal of Cancer|2024Cited by 17